FDA approves the launch of the first 5-in-1 respiratory therapy system VOCSN
Recently, Ventec Life Systems, a US-based respiratory disease care total solution innovation company, said that the company's respiratory equipment VOCSN (the only portable device that integrates five respiratory therapies, formerly known as VOX-SEN) received the US FDA. With 510(k) registration approval, the device integrates five respiratory treatment options: ventilation, oxygen, cough, aspiration, and nebulization.
The VOCSN device has the characteristics of care continuity and can be used in hospitals or in the home. It can be used in children from over 5 kg in weight to adult patients. VOCSN is primarily designed to improve the daily care of patients with neuromuscular diseases such as muscular dystrophy and amyotrophic lateral sclerosis, repairing chronic obstructive pulmonary disease, cystic pulmonary fibrosis, lung cancer and emphysema The patient's lung function, care of patients with spinal injuries, and care for children with progressive syndrome (including premature labor and chronic lung disease), patients can get a comprehensive treatment of five therapies using this device.
The VOCSN device is 70% lighter and smaller than the instruments on the market today. It has a 9-hour battery life battery, controlled and operated through an intuitive touch screen interface, and the operating system is friendly. By using the VOCSN, the medical staff can initiate the procedure for respiratory therapy with only one button and without having to change the patient circuit of the treatment process. The VOCSN reduces the time it takes for healthcare personnel to operate the instrument and allows more time to care for the patient itself.
Since the father of Ventec founder and CEO Doug DeVries was diagnosed with amyotrophic lateral sclerosis, he said he would work to develop better respiratory treatments for ventilator patients. Doug DeVries said: "I have clearly realized how to change the existing ventilator technology to enable patients and caregivers to achieve greater therapeutic results. Our team will not just design a ventilator, we have been in the past five years. Committed to developing a truly integrated respiratory treatment solution.†This device is a smaller and more efficient system, using new technologies to make it the best in its class. VOCSN is assembled and produced in the United States and has eight patents pending.
SHAANXI HAIBO BIOTECHNOLOGY CO., LTD , https://www.rozenbio.com